Unity Biotechnology Performance
| UBXDelisted Stock | USD 0.16 0.01 6.67% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Unity Biotechnology are completely uncorrelated. Unity Biotechnology right now has a risk of 0.0%. Please validate Unity Biotechnology daily balance of power , to decide if Unity Biotechnology will be following its existing price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Unity Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental drivers, Unity Biotechnology is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 20.7 M | |
| Total Cashflows From Investing Activities | 8.6 M |
Unity |
Unity Biotechnology Relative Risk vs. Return Landscape
If you would invest 16.00 in Unity Biotechnology on October 3, 2025 and sell it today you would earn a total of 0.00 from holding Unity Biotechnology or generate 0.0% return on investment over 90 days. Unity Biotechnology is generating negative expected returns assuming volatility of 0.0% on return distribution over 90 days investment horizon. In other words, 0% of stocks are less volatile than Unity, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Unity Biotechnology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Unity Biotechnology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Unity Biotechnology, and traders can use it to determine the average amount a Unity Biotechnology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| UBX |
Based on monthly moving average Unity Biotechnology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Unity Biotechnology by adding Unity Biotechnology to a well-diversified portfolio.
Unity Biotechnology Fundamentals Growth
Unity Stock prices reflect investors' perceptions of the future prospects and financial health of Unity Biotechnology, and Unity Biotechnology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Unity Stock performance.
| Return On Equity | -2.31 | |||
| Return On Asset | -0.39 | |||
| Current Valuation | 3.53 M | |||
| Shares Outstanding | 17.21 M | |||
| Price To Book | 2.59 X | |||
| Price To Sales | 6.54 X | |||
| EBITDA | (25.12 M) | |||
| Cash And Equivalents | 64.51 M | |||
| Cash Per Share | 9.26 X | |||
| Total Debt | 23.54 M | |||
| Debt To Equity | 1.30 % | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (20.86 M) | |||
| Earnings Per Share | (1.63) X | |||
| Total Asset | 37.66 M | |||
| Retained Earnings | (510.34 M) | |||
About Unity Biotechnology Performance
Evaluating Unity Biotechnology's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Unity Biotechnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Unity Biotechnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California. Unity Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 65 people.Things to note about Unity Biotechnology performance evaluation
Checking the ongoing alerts about Unity Biotechnology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Unity Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Unity Biotechnology is not yet fully synchronised with the market data | |
| Unity Biotechnology has some characteristics of a very speculative penny stock | |
| Unity Biotechnology has a very high chance of going through financial distress in the upcoming years | |
| Reported Net Loss for the year was (25.99 M) with loss before taxes, overhead, and interest of (12.06 M). | |
| Unity Biotechnology has about 64.51 M in cash with (20.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.26, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Unity Biotechnology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Unity Biotechnology's stock is overvalued or undervalued compared to its peers.
- Examining Unity Biotechnology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Unity Biotechnology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Unity Biotechnology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Unity Biotechnology's stock. These opinions can provide insight into Unity Biotechnology's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Unity Stock
If you are still planning to invest in Unity Biotechnology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Unity Biotechnology's history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |